Literature DB >> 28538250

Cardiac Abnormalities in Type 1 Facioscapulohumeral Muscular Dystrophy.

Fabien Labombarda1, Maxime Maurice, Jean-Philippe Simon, Damien Legallois, Lucie Guyant-Maréchal, Anne-Laure Bedat-Millet, Philippe Merle, Eric Saloux, Françoise Chapon, Paul Milliez.   

Abstract

OBJECTIVES: We conducted a retrospective study to characterize the cardiac complications in patients with genetically confirmed type 1 facioscapulohumeral dystrophy.
METHODS: We reviewed baseline cardiac investigations, including electrocardiogram, Holter electrocardiogram and echocardiogram, as well as cardiac complications that occurred during follow-up in 56 adult patients (37 men, mean duration of disease: 20 years).
RESULTS: Baseline evaluation revealed minor cardiac anomalies in 23 patients including incomplete right bundle branch block (iRBBB) in 13 patients (23%). Over a mean follow-up period of 7.2 years, there was no cardiac death, no patient developed cardiomyopathy, and 28 patients (50%) experienced cardiac anomalies. Among these patients, 3 had one or more major events (heart failure and/or atrial fibrillation). The remaining 25 patients presented minor cardiac anomalies of which iRBBB was the most frequent (25%).
CONCLUSIONS: Cardiac anomalies identified during the follow-up of patients with type 1 facioscapulohumeral dystrophy are mainly minor anomalies, dominated by the iRBBB.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28538250     DOI: 10.1097/CND.0000000000000144

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


  5 in total

1.  Cardiac Involvement in Facioscapulohumeral Muscular Dystrophy (FSHD).

Authors:  Allison Ducharme-Smith; Stefan Nicolau; C Anwar A Chahal; Kirstie Ducharme-Smith; Shujah Rehman; Keerthi Jaliparthy; Nadeem Khan; Christopher G Scott; Erik K St Louis; Teerin Liewluck; Virend K Somers; Grace Lin; Peter A Brady; Margherita Milone
Journal:  Front Neurol       Date:  2021-05-24       Impact factor: 4.003

2.  Cardiac involvement in a cross-sectional cohort of myotonic dystrophies and other skeletal myopathies.

Authors:  Johannes Schmid; Meinrad Beer; Andrea Berghold; Tatjana Stojakovic; Hubert Scharnagl; Benjamin Dieplinger; Stefan Quasthoff; Josepha S Binder; Peter P Rainer
Journal:  ESC Heart Fail       Date:  2020-05-31

3.  Evaluation of Myocardial Strain by 2-Dimensional Speckle Tracking Echocardiography in Patients with Facioscapulohumeral Muscular Dystrophy.

Authors:  Ferhat Işık; Abdurrahman Akyüz; Murat Çap; Askeri Türken; Süleyman Varsak; Erkan Baysal
Journal:  Anatol J Cardiol       Date:  2022-07       Impact factor: 1.475

Review 4.  Diagnosis of Cardiac Abnormalities in Muscular Dystrophies.

Authors:  Elisabeta Bădilă; Iulia Ioana Lungu; Alexandru Mihai Grumezescu; Alexandru Scafa Udriște
Journal:  Medicina (Kaunas)       Date:  2021-05-12       Impact factor: 2.430

5.  A case of type 1 facioscapulohumeral muscular dystrophy (FSHD) with restrictive ventilatory defect and congestive heart failure.

Authors:  Nobutoshi Morimoto; Mizuki Morimoto; Yoshiaki Takahashi; Motonori Takamiya; Ichizo Nishino; Koji Abe
Journal:  eNeurologicalSci       Date:  2020-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.